ReGenesys

ReGenesys

Foundation date

17/10/2005

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Cell therapy
• #Therapeutics - Stem cells

Therapeutic areas

• #Cardiovascular
• #Musculoskeletal system and connective tissue
• #Respiratory system

ReGenesys BV is a wholly-owned subsidiary of Athersys, Inc. (NASDAQ: ATHX), a biotechnology company in Cleveland, Ohio, U.S.A., that is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product initially for disease indications in the neurological, cardiovascular, inflammatory and immune areas.  Athersys has several ongoing clinical trials to evaluate its MultiStem product candidate.